PCTAIRE1 phosphorylates p27 and regulates mitosis in cancer cells

Teruki Yanagi1, Maryla Krajewska1, Shu-ichi Matsuzawa2

  • 1Sanford-Burnham Medical Research Institute, La Jolla, California.

Cancer Research
|September 11, 2014
PubMed

Insights

PCTAIRE1, a cyclin-dependent kinase relative, drives cancer cell growth by affecting p27 stability and mitosis. Silencing PCTAIRE1 inhibits tumor growth, suggesting it as a potential cancer therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • PCTAIRE1, a distant relative of cyclin-dependent kinases, is linked to spermatogenesis and neuronal development but unstudied in cancer.
  • Its role in cancer progression and potential as a therapeutic target remain unexplored.

Purpose of the Study:

  • To investigate the role of PCTAIRE1 in cancer.
  • To identify PCTAIRE1's interacting partners and elucidate its mechanism of action in cancer cells.
  • To evaluate PCTAIRE1 as a potential therapeutic target for cancer treatment.

Main Methods:

  • RNA interference (RNAi)-mediated silencing of PCTAIRE1 in various cancer cell lines (prostate, breast, cervical).
  • Yeast two-hybrid screening to identify PCTAIRE1 interacting proteins.
  • In vitro kinase assays to determine PCTAIRE1's phosphorylation activity on p27.
  • Cell cycle analysis and centrosome dynamics assessment.
  • Mouse xenograft models for in vivo tumor growth assessment.
  • Analysis of PCTAIRE1 expression in clinical tumor samples.

Main Results:

  • PCTAIRE1 is expressed in prostate, breast, and cervical cancer cells, and its silencing inhibits cancer cell growth.
  • PCTAIRE1 silencing leads to aberrant mitosis due to centrosome defects, specifically in cancer cells.
  • PCTAIRE1 interacts with and phosphorylates tumor suppressor p27 at Ser10, modulating its stability and accumulation.
  • Silencing PCTAIRE1 suppresses tumor growth in a prostate cancer xenograft model.
  • PCTAIRE1 is highly expressed in primary breast and prostate tumors compared to normal tissues.

Conclusions:

  • PCTAIRE1 plays a crucial role in regulating p27 stability, mitosis, and tumor growth in various cancers.
  • PCTAIRE1's specific involvement in cancer cell proliferation and its high expression in tumors highlight its potential as a therapeutic target.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K